Joining VeloClub not only supports the work we do, there are some fantastic benefits:
by Mark Zalewski
July 16, 2016
In today’s CT Daily News Digest: Dumoulin crushes Tour de France stage 13 TT, Froome extends GC lead; Gaviria gets hat trick in Poland; Prudhomme: It’s a day of mourning for France and for the Tour de France; After Nice attack, the Tour de France goes on with heavy hearts; Mont Ventoux madness: A first-hand perspective from the Tour; Porte, on chaotic Ventoux mishap: ‘If you can’t control the crowds, then what can you control?’; Maddeningly hypnotic: The Tour de France is an absurd, beautiful circus; Simon Gerrans out of the Tour de France with collarbone fracture; Thibaut Pinot out of Tour de France; Theuns crashes out of Tour de France in time trial crash; Shane Sutton: British Cycling review will exonerate me; Is EPO’s performance enhacing effect all in the mind?; Tour de France, stage 12 on-board highlights; OBE Backstage Pass, stage 12; A journey to the top: Peter Sagan
A new study by the Centre for Human Drug Research in the Netherlands argues that EPO use may have no physical performance enhancement effect.
48 trained cyclists from Holland and Belgium took part in a double-blind study where half were given EPO and half a placebo. Each week they did endurance tests, including VO2max, and gave blood samples.
“It’s the protocol used in pharmacology because it is rigorous. We hadn’t found any previous research into EPO of such rigour,” said Adam Cohen, chief executive of the centre.
This past June, after eight weeks, the entire group did did a 130km ride to the summit of Mont Ventoux. The initial results showed no difference between the two control groups, based on time.
The scientists will now dive into the data collected to determine more specific conclusions, including if the effects of taking EPO are only in the mind, and submit their findings for peer-reviewed publication.
Click through to read more at Cycling Weekly.